Molina · Medecine et maladies infectieuses 2020

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.

Cited 793 times in the scientific literature.

not yet graded

PubMed 32240719 · doi:10.1016/j.medmal.2020.03.006 · record verified 2026-08-30

Cited by

• supports An observational study of 11 severe COVID-19 patients found no clinical benefit from combined hydroxychloroquine and azithromycin treatment.in COVID-19 Q&A #1 with Rhonda Patrick, Ph.D.